Actively Recruiting
Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study
Led by Research Institute of Ophthalmology, Egypt · Updated on 2025-04-30
64
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The current study aims at assessing the efficacy and safety of oral Gabapentin alone versus Diclofenac Potassium drugs for postoperative analgesia in patients undergoing surface ablation.
CONDITIONS
Official Title
Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years old
- Stable refraction for at least one year before surgery
- Normal corneal shape with expected postoperative flat K reading not less than 38D
- Postoperative residual stromal bed thickness not less than 350 bcm
You will not qualify if you...
- Corrected distance vision worse than 20/30 before surgery
- Amblyopia (lazy eye)
- History of previous eye surgeries
- Herpetic eye infection or corneal dystrophies
- Other eye diseases such as uveal or retinal diseases, and glaucoma
- Diabetes
- High blood pressure
- Kidney problems
- Breathing problems
- Older than 65 years
- Previous allergy or adverse reaction to Gabapentin or Diclofenac potassium
- History of drug or alcohol abuse
- History of mood disorders, depression, suicidal thoughts or behavior
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Research Institute of Ophthalmolgy
Giza, Egypt
Actively Recruiting
Research Team
D
Dina Moustafa M Ali, MD
CONTACT
M
Mohamed Tarek Ahmed El- Naggar, MD- FRCS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here